These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10509210)

  • 1. What is appropriate disclosure?
    Cohen D
    Can Fam Physician; 1999 Sep; 45():2036, 2038. PubMed ID: 10509210
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpatient variations in antipsychotic therapy.
    McIntyre IM; Gershon S
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):3-5. PubMed ID: 2859279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR; Roth LH; Cornes CL
    Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patient education concerning late hyperkineses].
    Helmchen H
    Nervenarzt; 1991 May; 62(5):265-8. PubMed ID: 1678144
    [No Abstract]   [Full Text] [Related]  

  • 5. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive-dyskinesia and lithium-associated neuropathy.
    Rogers GA
    J Clin Psychiatry; 1981 Sep; 42(9):363-4. PubMed ID: 6115854
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic dosage, duration, and tardive dyskinesia.
    Allen RE; Stimmel GL
    Dis Nerv Syst; 1977 May; 38(5):385-7. PubMed ID: 852370
    [No Abstract]   [Full Text] [Related]  

  • 8. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

  • 9. Informed consent for the use of antipsychotic medications: one standard for all?
    Schwartz B
    Tex Med; 1986 Dec; 82(12):50-1. PubMed ID: 2880404
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antipsychotic medication in the elderly.
    Maletta GJ
    Annu Rev Gerontol Geriatr; 1984; 4():175-220. PubMed ID: 6152711
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics and the law.
    Fitzgerald P
    Aust N Z J Psychiatry; 2002 Aug; 36(4):560-1. PubMed ID: 12169161
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term changes in AIMS ratings and their relation to medication history [proceedings].
    Smith JM; Burke MP; Moon CO
    Psychopharmacol Bull; 1981 Jan; 17(1):120-1. PubMed ID: 7232640
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic-induced movement disorders: deconstructing extrapyramidal symptoms.
    Trosch RM
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S266-71. PubMed ID: 15541167
    [No Abstract]   [Full Text] [Related]  

  • 16. [Severe late dystonia due to fluspirilen].
    Rittmann M; Steegmanns-Schwarz I
    Dtsch Med Wochenschr; 1991 Oct; 116(42):1613. PubMed ID: 1682121
    [No Abstract]   [Full Text] [Related]  

  • 17. Informed consent: recall about tardive dyskinesia.
    Jaffe R
    Compr Psychiatry; 1981; 22(4):434-7. PubMed ID: 6114809
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
    Bollini P; Pampallona S; Orza MJ; Adams ME; Chalmers TC
    Psychol Med; 1994 May; 24(2):307-16. PubMed ID: 7916157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on legal issues associated with tardive dyskinesia.
    Slovenko R
    J Clin Psychiatry; 2000; 61 Suppl 4():45-57. PubMed ID: 10739331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia. A joint statement of the Adverse Drug Reactions Advisory Committee and the Psychotropic Drug Committee of The Royal Australian and New Zealand College of Psychiatrists.
    Med J Aust; 1983 Aug; 2(4):195-6. PubMed ID: 6135977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.